In vaccine development, activating the immune system is the major challenge. In this perspective, transcutaneous immunization (TCI) offers an attractive approach due to the presence of abundant antigen presenting cells (APCs) such as Langerhans cells and dendritic cells. In particular transfollicular vaccination aims to deliver antigens to the abundant perifollicular APCs without compromising the SC barrier function. The present work clearly demonstrates the potential of transfollicular immunization as an approach to deliver antigens across intact skin following co-administration of nanoparticles with an adjuvant on intact skin as well as stimulating and modulating efficient humoral and cellular immune response according to the specific clinical needs. 
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Background
Vaccination is one of the most promising strategies to prevent infectious diseases. Its potential therapeutic use against communicable and non-communicable (e.g. cancer)
diseases is also attracting considerable interest. However, to meet the current challenges of vaccine delivery an easy-to-use, needle-free and non-invasive delivery system is needed. 1 In this perspective, transcutaneous immunization (TCI) offers an attractive approach for the development of highly accepted and needle-free vaccines, which are not only safe but also effective due to the presence of abundant professional antigen presenting cells (APCs), such as dendritic cells (DCs) and Langerhans cells (LCs), in different layers of the skin.
However, the main challenge for TCI is to enhance the transport of antigens across the stratum corneum (SC) barrier. To this end, reversible barrier disruption methods are often applied, such as chemical permeation enhancers, abrasion, electroporation, micro-needles, PowderJect and gene gun. 2 In contrast, TF vaccination aims to deliver antigens to the abundant peri-follicular APCs without compromising the SC barrier function. 3 Nanoparticles (NPs) have been shown to be ideal vehicles for TF delivery, since they preferentially accumulate and penetrate deeper into hair follicles than conventional formulations. 4 In our previous studies, we have shown that this holds also true in case of delivery of antigenic molecules encapsulated into NPs not only in terms of penetration of antigen in hair follicles but also quantitatively. We observed 2-3 times higher antigen amounts in the hair follicles of excised pig ear skin, when the antigen had been encapsulated in NPs as compared to antigen applied as solution. 5 However, TF vaccination is usually performed after pre-treating the skin area by plucking hairs, waxing or cyanoacrylate (superglue) stripping. [6] [7] [8] Pre-treatment not only permeabilizes the skin by removing the upper layers of the SC, but also activates the innate immune system. 1 While both factors probably improve the immunogenicity of a topically applied vaccine, the disadvantage of the method is that permeabilization of the skin increases considerably the risk of infections. 9 Thus, for various purposes, such as mass vaccination campaigns or vaccination of immune-compromised individuals, elderly, people with poor wound healing or young children these strategies are suboptimal.
Our previous studies investigated the potential of the TF route for the delivery of antigen using NPs without pre-treating the skin for the purpose of non-invasive TCI. As a proof of concept, we showed the successful delivery of antigen via the TF route using antigen-loaded NPs in an adoptive transfer mouse model by measuring the proliferation of antigen-specific CD4+ T cells. 5 Although the adoptive transfer model demonstrated the viability of this vaccination route, the experimental setting does not resemble a true vaccination. The proliferation of ovalbumin (OVA)-specific CD4+ T cells provides a hint on the feasibility of this approach. However, while in a normal mouse antigen-specific T cells are supposed to be in a ratio of 1 in 100,000, this ratio is artificially elevated to at least 1 in 100 by the adoptive transfer method.
Here, we extended our in vivo mouse studies in a normal vaccination setting to confirm the viability of the TF route, as well as to obtain deeper insights in the immune responses generated using NPs without pre-treatment of the skin. To this end, vaccination experiments were performed in conventional mice in which i) skin integrity and maintenance of the skin barrier function was monitored throughout the experiment, ii) immune responses generated by applying different formulations on tape stripped and intact skin were compared, and iii) immune responses generated by applying antigen-loaded NPs on skin without compromising the SC barrier in the presence or absence of an adjuvant were extensively characterized.
The obtained results should assist in the rational designing of particulate formulations for prophylactic or therapeutic vaccination via the TF route.
Methods

Particle preparation
OVA-loaded Chitosan-PLGA (Chit-PLGA) NPs were prepared by a modified double emulsion method (more details in supplementary materials). 
Measurement of transepidermal water loss (TEWL)
TEWL was assessed on the dorsal side of flank part of four C57BL/6 mice skin using an AquaFlux AF200 which operates with a closed measurement chamber (Biox Systems Ltd., London, UK). Measurements of TEWL were taken on day 0 (of untreated skin, serving as control reading, and again after performing depilation), on day 1 and day 2, according to the manufacturer's instructions.
Immunization protocols
Immunization was carried out on the flanks of the mice. In brief, 2 days before the immunization mice were anesthetized and hair was removed using clippers and a depilatory cream. Depilated areas were carefully inspected for cuts or skin irritation, in which case these mice were excluded from the experiment.
Female C57BL/6 mice (n = 5) were immunized on day 0, 14, 28 and 42 by applying 60 µl of different formulations containing 200 µg of LPS-free OVA topically to an area of 2.25 cm² of either intact or tape stripped skin (Table 1) .
Tape stripping was performed as follows: 5 successive adhesive tapes ( Tesafilm kristallklar, Tesa SE, Germany) were removed from the application area. For each stripping, a fresh piece of tape was lightly pressed onto the skin and subsequently pulled off. Directly after stripping, control or vaccine formulations were applied and allowed to dry completely. During this procedure the mice remained anesthetized to secure optimal uptake of the formulations.
In vivo localization of nanoparticles using histopathology
Histo-pathologic studies were performed on skin sites 4 h after topical application of DiD 
Sample collection
Blood samples from immunized mice were taken from the retro-orbital complex on day −1, 13, 27, 41 and 56 (more details in supplementary materials).
Detection of antigen-specific IgG and IgG subtypes
OVA-specific antibodies in sera of individual animals were determined by ELISA, using microtiter plates coated with 100 µl/well (OVA 2 µg/ml in 0.05 M carbonate buffer, pH 9.6), as previously described (more details in supplementary materials).
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Measurement of cellular proliferation
Spleen and lymph node cells of vaccinated mice were obtained by mashing the organs and subsequently lysing erythrocytes for 1 min with ammonium chloride (ACK) buffer, as previously described (more details in supplementary materials). 
Multifunctional T cells
In order to evaluate the capacity of the different vaccine formulations to stimulate OVAspecific multifunctional T cells, splenocytes from immunized mice were taken and their capacity to produce different cytokines was evaluated by flow cytometry (more details in supplementary materials).
Statistical analysis
The statistical significance of the differences between experimental groups was analyzed using one way ANOVA. Differences were considered significant at p<0.05 (*) and highly significant at p<0.001(***).
Results
Characterization of OVA-loaded Chit-PLGA NPs
The characteristics of the NPs are summarized in Table 2 . The mean size of OVA-loaded Chit-PLGA NPs was ca. 180 nm and a monodisperse size distribution (PDI < 0.2). The particles carried a positive surface charge and had an entrapment efficiency (wt OVA encapsulated/wt OVA added initially) of 30.85% ± 1.08% and % loading (wt OVA encapsulated/wt polymer) 6.65% ± 0.18%. Admixing the adjuvant to the OVA-loaded NPs did not change the particle characteristics in terms of size and charge (data not shown).
TEWL Measurement
TEWL measures the skin barrier towards water and is a well-established non-invasive tool in dermatology to assess the integrity of the skin barrier in vivo and for testing skin irritancy.
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Its high sensitivity allows detecting clinically invisible damage to the skin induced by various physical and chemical injuries. When skin is damaged, its barrier function is impaired resulting in higher trans-epidermal water loss. To evaluate if the skin barrier was intact on the day of immunization, i.e. 2 days after depilation, TEWL was measured before treatment, directly after depilation and on two subsequent days. Just 30 min after depilation, the TEWL measurement of the depilated area was twice that of normal untreated skin, thereby showing the barrier disruption via this procedure even in the absence of any visible cut or irritation of the skin. As shown in Figure. 1, the skin barrier recovered to its normal value within 2 days of the depilation procedure.
In vivo localization of nanoparticles by histopathology
Applying antigenic solutions onto intact skin usually does not result in the stimulation of immune responses as the SC forms a barrier towards penetration of foreign substances.
However, NPs are preferentially taken up into hair follicles and accumulate in the upper duct (infundibulum). Figure 2 shows a representative image illustrating the distribution of DiD (fluorescently dye) loaded Chit-PLGA NPs on the skin surface and in the hair follicle after application to mouse skin. It is apparent that the NPs accumulated in the follicle openings, cover the hair and invade into the follicular duct.
Characterization of immune responses induced after vaccination Humoral immune responses
Serum anti-OVA IgG antibody levels obtained after TF vaccination with OVA and OVAloaded NPs with or without co-administration of bis-(3',5')-cyclic dimeric adenosine monophosphate (c-di-AMP) as adjuvant on intact or tape stripped skin are shown in Figure   3A . OVA alone applied onto the intact skin or tape stripped skin promotes very low IgG titer. 
T cell responses following vaccination
Beside the magnitude of cellular responses, vaccine efficacy also depends on the quality of the stimulated antigen-specific T cell responses. There is consensus that multifunctional T cells are associated with enhanced protection against infection, likely based on a broader functional spectrum. 
Discussion
It is quite evident in literature that skin is an attractive organ for immunization that can be easily manipulated for vaccination purposes. Recently, the topical delivery of antigens formulated into particulate delivery systems has evoked considerable interest. NPs have been shown to be promising carriers for TCI and for modulating the immune response depending on the site of delivery. 13 In particular, TF vaccination using NPs holds potential for non-invasive and needle-free vaccine delivery without disrupting the barrier properties of the skin. Thus, it has been shown that NPs of a size of approx. 200 nm were taken up by the LCs located around the hair follicles. 6 Moreover, TCI with antigen (gp100 protein) loaded chitosan NPs was shown to improve the survival of tumor bearing mice in comparison to antigen solution. 14 However, it remains unclear, if the particles were applied on intact or tape stripped skin. 14 Stripping results not only in mild to moderate skin disruption, but also activates the innate immune system. Mattheolabakis et al. showed the efficacy of TCI following a prime-boost protocol using OVA-loaded poly-lactic acid NPs. 16 Mice received a priming and a 1 st boost immunization via the topical route, whereas the 2 nd boost was administered via the subcutaneous route. 16 Although even modest barrier disruption is immunostimulatory and results in increased immune responses, disruption of the skin barrier considerably increases the risk of infection. This is particularly important in countries with low hygiene standards and for mass vaccination campaigns in which it is impossible to prescreen vaccines to identify those with high risk for infections. In the present study an in depth characterization of the immune responses stimulated after TF immunization using NPs as a needle-free vaccination strategy without any barrier disrupting measure is described.
For this purpose it is essential to demonstrate skin integrity and the maintenance of skin barrier function following hair trimming and depilation throughout the experiment.
Interestingly, when we evaluated the skin integrity by TEWL measurement before and after depilation we found that TEWL doubled those of the normal untreated skin already 30 min after depilation. Thus, although there was no visible skin damage or irritation, the barrier function of the skin was narrowed. However, the skin seemed to recover fully within 2 days after depilation, as TEWL values returned to the baseline levels observed before depilation.
Therefore, this study revealed that careful analysis of the skin barrier integrity is mandatory before applying the formulation on depilated skin. This is particularly important considering that, according to the literature formulations are often applied immediately or within 30 min of depilation.
Humoral immune responses observed after applying different vaccine formulations on intact and tape stripped skin were compared. OVA-loaded NPs applied on tape stripped skin promoted significantly higher anti-OVA IgG titer in comparison to OVA-loaded NPs applied on intact skin. This result is in agreement with the studies done by Li et al. showing an increase of IgG response after stripping the skin which might be due to both increased penetration and stimulation of the innate immune system by the mild barrier disruption caused by tape stripping. CD8+ responses were stronger in mice tape stripped prior to vaccination with OVA or OVANPs. 13 However, co-administration of c-di-AMP surpassed skin disruption and stimulated the strongest antigen-specific CD8+ responses. Furthermore, this formulation also increases the quality of the immune responses by stimulating antigen-specific multifunctional CD8+ T cells, which were shown to be more efficient in terms of killing as compared to single producers.
More specifically, TF immunization via intact skin with OVA-NPs + c-di-AMP stimulated CD8+ T cells that secrete both IFN and TNFα and IFN and IL-2 (data not shown). While IL-2 is needed in order to expand T cell responses which in turn could enhance CD8+ T cell memory, IFN and TNFα co-producers have enhanced cytolytic activity. In addition, OVANPs co-administered with c-di-AMP also increased the quality of the stimulated T helper responses as indicated by the elicitation of antigen-specific multifunctional CD4+ T cells. This is of interest, as these cells were shown to be essential, rather than CD8+ T cells, in order to protect against different pathogens.
In summary, the results presented in this study provide the proof-of concept for the potential of NP-based TF vaccination as an approach to deliver antigens across intact skin.
Incorporation of an adjuvant in the formulation seems to be essential in order to generate both efficient antigen-specific humoral and cellular responses without breaching the skin barrier as well as to modulate such responses according to the specific clinical needs. 
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